Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells

被引:11
|
作者
Watanabe, A
Kurabayashi, M
Arai, M
Sekiguchi, K
Nagai, R
机构
[1] Gunma Univ, Sch Med, Dept Internal Med 2, Gunma 3718511, Japan
[2] Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan
关键词
growth factors; protein kinases; remodeling; signal transduction; smooth muscle;
D O I
10.1016/S0008-6363(01)00274-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Aberrant regulation of the synthesis and degradation of the extracellular matrix (ECM) is associated with the pathophysiology of vascular disease. Plasminogen activator inhibitor-1 (PAI-1) plays a crucial role in regulating the quantity and composition of ECM. However. regulatory mechanisms underlying the expression of the PAI-1 gene remain unclear. We examined the effects of all-trans-retinoic acid (atRA), either alone or in combination with mitogenic growth factor, basic fibroblast growth factor (bFGF), on the PAI-1 expression in cultured vascular smooth muscle cells (SMCs). Methods: Cultures of the rabbit vascular smooth muscle cell line C2/2 were used to study the effects: of atRA and bFGF separately or together. Results: Treatment of vascular SMCs with atRA in combination with bFGF resulted in an additional increase in PAI-1 expression both at the mRNA and protein levels. In contrast. tissue-type plasminogen activator. urokinase-type plasminogen activator and tissue factor mRNA levels were only minimally affected. The all-trans-RA- and bFGF-mediated increases in PAI-1 mRNA levels were markedly attenuated by the tyrosine kinase inhibitor genistein. but not by MEK1 or p38MAP kinase inhibitors. The rate of decrease in PAI-1 mRNA levels after actinomycin D treatment was not affected by atRA and bFGF. Transient transfection of the PAI-1 promoter-luciferase reporter gene, which contains 967 bp of the 5'-flanking region of the human PAI-1 gent, revealed that atRA and bFGF additionally increased transcription from this promoter. progressive 5'-deletion revealed that the promoter region required for such an effect lies between -967 and -260, which contains no canonical sequence for the RA-response element. In agreement with the role of PAI-1 in the inhibition of fibrinolytic activity which stimulates ECM degradation, cell migration was inhibited by treatment with atRA and bFGF. Conclusions: These results indicate that atRA and bFGF can function in a combined fashion and induct PAI-1 synthesis in vascular SMCs, and suggest a role for these two compounds in regulating SMC migration. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:151 / 159
页数:9
相关论文
共 50 条
  • [31] Retinoic acid suppresses angiotensin II-induction of TGF beta gene expression in vascular smooth muscle cells.
    Wagner, J
    Ritz, E
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1426 - A1426
  • [32] Attenuation of PAI-1 synthesis by troglitazone in human arterial smooth muscle cells is affected by the 4g/5g polymorphism in the promoter of the PAI-1 gene
    Nordt, TK
    Eschenfelder, E
    Peter, K
    Sobel, BE
    Bode, C
    CIRCULATION, 2000, 102 (18) : 47 - 47
  • [33] Role of basic FGF in the exaggerated growth of vascular smooth muscle cells from SHR
    Nakayama, M
    Fukuda, N
    Hu, WY
    Kishioka, H
    Satoh, C
    Kanmatsuse, K
    JOURNAL OF HYPERTENSION, 2000, 18 : S199 - S199
  • [34] TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) SYNTHESIS BY VASCULAR SMOOTH-MUSCLE CELLS (SMC) AND THEIR ABILITY TO INFLUENCE ENDOTHELIAL-CELL PAI-1 SYNTHESIS
    CHRIST, G
    HUFNAGL, P
    WOJTA, J
    BINDER, BR
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1247 - 1247
  • [35] Liraglutide inhibits hyperglycemia induced PAI-1 expression in vascular endothelial cells
    Simpson, Richard W.
    Knudsen, Lotte B.
    Bin Liu, Hong
    Dear, Anthony E.
    DIABETES, 2008, 57 : A150 - A150
  • [36] Plasminogen Activator Inhibitor-1 (PAI-1) Increases Mitochondrial Membrane Potential In Vascular Smooth Muscle Cells And Coronary Arteries
    Schoenherr, Alex
    Norton, Charles
    Vadali, Manisha
    Bryson, Alaina
    Fay, William P.
    Ji, Yan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [37] CRP induces PAI-1 gene expression through tyrosine kinase and NFkB pathways in vascular endothelial cells
    Kawanami, D
    Maemura, K
    Takeda, N
    Harada, T
    Nojiri, T
    Imai, Y
    Nagai, R
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 331 - 331
  • [38] Induction of PAI-1 synthesis by growth factors in human arterial smooth muscle cells is independent of the 4G/5G polymorphism in the promoter of the PAI-1 gene
    Nordt, TK
    Esohenfelder, E
    Ruef, J
    Peter, K
    Sobel, BE
    Bode, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 280A - 280A
  • [39] Chronic angiotensin II administration increases PAI-1 mRNA expression in rat aortic smooth muscle cells in vivo
    Castoldi, G
    di Gioia, CRT
    Redaelli, S
    Rosati, R
    Stella, A
    HYPERTENSION, 2003, 42 (04) : 638 - 638
  • [40] Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1)
    Schneider, DJ
    Hayes, M
    Wadsworth, M
    Taatjes, H
    Rincón, M
    Taatjes, DJ
    Sobel, BE
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 (08) : 1091 - 1099